TITLE

Billion-dollar price tag on Merck Vioxx settlement

AUTHOR(S)
Arnold, Matthew
PUB. DATE
January 2012
SOURCE
Medical Marketing & Media;Jan2012, Vol. 47 Issue 1, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on an estimated 1 billion dollars settlement of litigation of Merck and Co. Inc.'s Vioxx, a Cox-2 pain drug found to cause stroke and heart attacks.
ACCESSION #
70125497

 

Related Articles

  • 94% of patients suing Merck over rofecoxib agree to terms of company's offer. Charatan, Fred // BMJ: British Medical Journal (International Edition);3/15/2008, Vol. 336 Issue 7644, p580 

    The article reports on a decision from 94% of patients suing Merck to accept a settlement agreement which the company offered to them. The litigants sued Merck as a result of developing side effects from the company's drug Vioxx. Merck announced the $4.98 billion settlement in November of 2007,...

  • Benefits Brouhaha.  // njbiz;12/16/2002, Vol. 15 Issue 51, p4 

    Reports on the lawsuit settlement of Merck with its employees and Medco subsidiary. Amount of the settlement offered by the company; Information on the lawsuit.

  • Merck Tries to Settle Benefit Case. Branch Jr., Al // Pharmaceutical Executive;Jan2003, Vol. 23 Issue 1, p20 

    Reports that Merck and its Medco Health pharmacy benefits division will settle cases alleging the company misled customers and insurers into buying higher-priced medicines. Total amount to be paid by Merck to settle the case; Details of the settlement; Background of the case.

  • Doctor's failure to monitor possible drug reaction leads to toxicity for child and $600,000 settlement. Delaney, Blake J. // Healthcare Risk Management;Jul2007, Vol. 29 Issue 7, p1 

    The article focuses on the failure of a doctor to monitor possible drug reaction in a child which led to toxicity for the patient and $600,000 settlement.

  • GP pays out £15,000 to patient.  // Pulse;1/6/2003, Vol. 63 Issue 1, p4 

    Reports on the out-of-court settlement between a general practitioner and patient over the failure of the physician to identify a serious side-effect caused by the drug prescribed in Bristol, England.

  • How does a painkiller harm the heart? Wadman, Meredith // Nature;5/18/2006, Vol. 441 Issue 7091, p262 

    The article reports on the publication of studies confirming that the painkiller Vioxx from Merck and Co. Inc. can cause heart attack. A study published in the "Canadian Medical Association Journal" show that Vioxx caused heart attack within days of users first taking it. The other study suggest...

  • COX-2s: regulatory action on the horizon?  // PharmaWatch: Monthly Review;Mar2005, Vol. 4 Issue 3, p25 

    The article reports on the discussion initiated by the European Medicines Agency concerning to all the companies affected by Merck & Co. Inc.'s withdrawal of Vioxx, a COX-2 inhibitor. The agency has investigated the cardiovascular side effects of the said drug. It has also included alternative...

  • Drug to treat high cholesterol at center of billion-dollar suit against Merck. Townes, Glenn // New York Amsterdam News;1/24/2008, Vol. 99 Issue 5, p26 

    The article reports that a lawsuit has been filed against Merck & Co. Inc. It is mentioned that several New York City-based law firms have claimed that the drug company mislead consumers and withheld substantive information about its popular cholesterol-lowering drug Vytorin. It is stated that...

  • Merck settles Vioxx lawsuits. Townes, Glenn // New York Amsterdam News;11/22/2007, Vol. 98 Issue 48, p31 

    The article reports that Merck & Co. Inc. will be paying nearly $5 billion in order to settle legal claims to patients that used the drug Vioxx, manufactured by it. It is stated that the controversy surrounding the use of Vioxx has dogged Merck for the last several years However, shortly after...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics